GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (SZSE:300534) » Definitions » Cyclically Adjusted Price-to-FCF

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Cyclically Adjusted Price-to-FCF : 128.38 (As of Jun. 07, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Gansu Longshenrongfa Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-07), Gansu Longshenrongfa Pharmaceutical Industry Co's current share price is ¥10.27. Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ¥0.08. Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF for today is 128.38.

The historical rank and industry rank for Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:300534' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 58.75   Med: 83.52   Max: 134.77
Current: 134.77

During the past years, Gansu Longshenrongfa Pharmaceutical Industry Co's highest Cyclically Adjusted Price-to-FCF was 134.77. The lowest was 58.75. And the median was 83.52.

SZSE:300534's Cyclically Adjusted Price-to-FCF is ranked worse than
87.73% of 326 companies
in the Drug Manufacturers industry
Industry Median: 31.405 vs SZSE:300534: 134.77

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Gansu Longshenrongfa Pharmaceutical Industry Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ¥-0.136. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.08 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Gansu Longshenrongfa Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gansu Longshenrongfa Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Chart

Gansu Longshenrongfa Pharmaceutical Industry Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 90.49

Gansu Longshenrongfa Pharmaceutical Industry Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 60.92 86.24 90.49 108.58

Competitive Comparison of Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Gansu Longshenrongfa Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=10.27/0.08
=128.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Gansu Longshenrongfa Pharmaceutical Industry Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.136/115.1156*115.1156
=-0.136

Current CPI (Mar. 2025) = 115.1156.

Gansu Longshenrongfa Pharmaceutical Industry Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 99.000 0.000
201509 0.000 100.500 0.000
201512 0.000 100.600 0.000
201603 -0.124 102.200 -0.140
201606 -0.070 101.400 -0.079
201609 0.033 102.400 0.037
201612 -0.011 102.600 -0.012
201703 -0.148 103.200 -0.165
201706 -0.081 103.100 -0.090
201709 -0.048 104.100 -0.053
201712 0.087 104.500 0.096
201803 -0.065 105.300 -0.071
201806 -0.018 104.900 -0.020
201809 0.013 106.600 0.014
201812 0.089 106.500 0.096
201903 -0.015 107.700 -0.016
201906 -0.032 107.700 -0.034
201909 -0.026 109.800 -0.027
201912 0.072 111.200 0.075
202003 -0.108 112.300 -0.111
202006 -0.005 110.400 -0.005
202009 0.042 111.700 0.043
202012 0.148 111.500 0.153
202103 0.009 112.662 0.009
202106 0.035 111.769 0.036
202109 0.035 112.215 0.036
202112 0.090 113.108 0.092
202203 0.075 114.335 0.076
202206 0.021 114.558 0.021
202209 -0.069 115.339 -0.069
202212 0.773 115.116 0.773
202303 -0.155 115.116 -0.155
202306 -0.054 114.558 -0.054
202309 0.018 115.339 0.018
202312 0.093 114.781 0.093
202403 0.373 115.227 0.373
202406 0.053 114.781 0.053
202409 -0.061 115.785 -0.061
202412 -0.063 114.893 -0.063
202503 -0.136 115.116 -0.136

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Gansu Longshenrongfa Pharmaceutical Industry Co  (SZSE:300534) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Gansu Longshenrongfa Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Gansu Longshenrongfa Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Gansu Longshenrongfa Pharmaceutical Industry Co Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Guofang Road, Dingyuan Town, Yuzhong County, Gansu Province, Lanzhou, CHN, 730102
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat and dispel dampness, among others.
Executives
Chen Yao Wu Executives
Zhang Jin De Director
Zhang Fan Executives
Kong Jian Feng Executives
Yue Qing Xin Supervisors
Kang Yong Hong Executives

Gansu Longshenrongfa Pharmaceutical Industry Co Headlines

No Headlines